Summary
Alessandro Hammond is a physician-scientist and entrepreneur with 13 years of experience at the intersection of AI, oncology, and biomedical research, currently a Schwarzman Scholar and founder-CEO of NxtCure. He co-founded Ivy League Consults and a 501(c)(3) mentoring nonprofit, and has held research and clinical roles at Memorial Sloan Kettering, Broad Institute, Boston Children’s Hospital, and Harvard Medical School. His work focuses on genomic determinants of metastatic burden and AI-driven cancer solutions, blending deep translational research with product-focused startup leadership. Based in Cambridge and enrolled in Yale’s MD/PhD program, he brings uncommon dual fluency in clinical care and machine learning-driven therapeutics development.
13 years of coding experience
4 years of employment as a software developer
Masters of Science, MS, Masters of Science, MS at Schwarzman Scholars
A.B., A.B. at Harvard University
MD/PhD, MD/PhD at Yale University
Chinese